7.89
-0.21
(-2.59%)
At close: January 24 at 4:00:01 PM EST
8.50
+0.61
+(7.73%)
Pre-Market: 4:05:10 AM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| DE LOS PINOS ELISABET Chief Executive Officer | Sale | Jan 21, 2025 | 436,104 |
| ELAZZOUZI AMY Officer | Sale | Jan 21, 2025 | 38,442 |
| FEDER JULIE B Chief Financial Officer | Sale | Oct 18, 2024 | 134,276 |
| HOPKINS JANET JILL Officer | Sale | Nov 18, 2024 | 151,693 |
| JOHNSON DAVID MICHAEL Director | Stock Award(Grant) | Jun 20, 2024 | 435,839 |
| KILROY CONOR General Counsel | Stock Award(Grant) | Apr 2, 2024 | 96,000 |
| MATRIX CAPITAL MANAGEMENT COMPANY, LP Beneficial Owner of more than 10% of a Class of Security | Purchase | Nov 9, 2023 | -- |
| MATTESSICH ANTONY CHARLES Director | Stock Award(Grant) | Jun 20, 2024 | 10,500 |
| PLAVSIC MARK Chief Technology Officer | Sale | Oct 16, 2024 | 121,132 |
| SRIVASTAVA SAPNA Director | Stock Award(Grant) | Jun 20, 2024 | 10,500 |
Related Tickers
BCAX Bicara Therapeutics Inc.
11.61
-3.05%
MBX MBX Biosciences, Inc.
10.75
-8.35%
TRDA Entrada Therapeutics, Inc.
12.84
-0.62%
CGEM Cullinan Therapeutics, Inc.
10.55
-0.09%
DAWN Day One Biopharmaceuticals, Inc.
12.21
-2.40%
ADVM Adverum Biotechnologies, Inc.
4.4900
-0.44%
SYRE Spyre Therapeutics, Inc.
21.60
-0.96%
DNTH Dianthus Therapeutics, Inc.
21.21
-4.80%
INZY Inozyme Pharma, Inc.
1.4100
+6.82%
NKTX Nkarta, Inc.
2.4900
-1.58%